Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

In this analysis of the ASTRAL trials (non-opioid substitution therapy [OST], n = 984; OST, n = 51) evaluating the once-daily, pan-genotypic regimen of sofosbuvir/velpatasvir for hepatitis C virus infection, OST did not impact completion, adherence, sustained virologic response (SVR12), or safety. S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Grebely, Jason, Dore, Gregory J., Zeuzem, Stefan, Aspinall, Richard J., Fox, Raymond, Han, Lingling, McNally, John, Osinusi, Anu, Brainard, Diana M., Subramanian, G. Mani, Natha, Macky, Foster, Graham R., Mangia, Alessandra, Sulkowski, Mark, Feld, Jordan J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106608/
https://ncbi.nlm.nih.gov/pubmed/27553377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw579
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados